U.S. market Closed. Opens in 6 hours 8 minutes

EHAB | Enhabit, Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 7.25 - 7.70
52 Week Range 6.85 - 11.74
Beta 1.76
Implied Volatility 122.62%
IV Rank 26.86%
Day's Volume 390,154
Average Volume 645,668
Shares Outstanding 50,283,306
Market Cap 383,661,625
Sector Healthcare
Industry Medical - Care Facilities
IPO Date 2022-06-23
Valuation
Profitability
Growth
Health
P/E Ratio -44.88
Forward P/E Ratio N/A
EPS -0.17
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 10,800
Country USA
Website EHAB
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
*Chart delayed
Analyzing fundamentals for EHAB we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is on medium level and Health is weak. For more detailed analysis please see EHAB Fundamentals page.

Watching at EHAB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on EHAB Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙